BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16574489)

  • 1. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis.
    Wollersheim J; Dautzenberg M; van de Griendt A; Sybesma B
    Transfus Apher Sci; 2006 Apr; 34(2):179-86. PubMed ID: 16574489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets.
    Vamvakas EC
    Clin Lab; 2010; 56(7-8):263-79. PubMed ID: 20857891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated platelet collection using the latest apheresis devices in an Indian setting.
    Agarwal P; Verma A
    Transfus Apher Sci; 2009 Oct; 41(2):135-8. PubMed ID: 19709930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Fenwal Amicus blood cell separator in double dose platelet collection.
    Gürak S; Arslan O
    Transfus Apher Sci; 2007 Feb; 36(1):69-72. PubMed ID: 17270496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of platelet yield by Haemonetics 30 . Based on literature and own observations.
    Rosenkvist J; Holsøe E; Freiesleben E; Sørensen H
    Scand J Haematol; 1980 Aug; 25(2):165-70. PubMed ID: 7466305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose.
    Goodnough LT; Kuter D; McCullough J; Brecher ME
    J Clin Apher; 1998; 13(3):114-9. PubMed ID: 9828021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
    Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
    Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
    Enein AA; Hussein EA; El Shafie S; Hallouda M
    J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
    Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
    Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: motivation to donate, altruism and aggression.
    Trimmel M; Lattacher H; Janda M
    Transfus Apher Sci; 2005 Oct; 33(2):147-55. PubMed ID: 16115800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].
    Lozano ML; Rivera J; Vicente V
    Med Clin (Barc); 2012 May; 138(12):528-33. PubMed ID: 21807386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany.
    Walther-Wenke G; Doerner R; Montag T; Greiss O; Hornei B; Knels R; Strobel J; Volkers P; Däubener W;
    Vox Sang; 2006 Apr; 90(3):177-82. PubMed ID: 16507017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.